Assessment of Differential Renal Function by CT in Living Donors
- Conditions
- Living Donor of Kidney
- Interventions
- Other: Differential renal function assessment by 4D CT
- Registration Number
- NCT02820376
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
The purpose of this study is to assess the degree of agreement of the measurement of differential renal function in living donors by CT (computed tomography) and SPECT (single photon emission computed tomography).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 51
- Kidney living donor candidate (approval given) undergoing a morphological and functional renal assessment
- Mandatory enrollment in a health security plan (French Social Security)
- Subject having signed an informed consent
- Contra-indications to computed tomography with iodinated contrast medium injection, or to scintigraphy
- Subjects with an abnormal urinary tract (unique kidney, ectopic kidney, horseshoe kidney)
- Subjets under a legal protection measure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description All patients Differential renal function assessment by 4D CT Differential renal function assessment by 4D CT: All patients will undergo both CT and SPECT assessment of differential renal function; each patient will be his own comparator
- Primary Outcome Measures
Name Time Method degree of agreement through study completion (2 years) Differential renal function (DRF) measured by each technique (CT and SPECT) Regions of interest will be drawn on each kidney and the aorta to obtain time-intensity curves and derive the Patlak plot; the Patlak model will then be used to determine the slope of each kidney and thus to calculate the differential renal function (percentage of each kidney in the total renal function).
Degree of agreement will be assessed by calculating the intra-class correlation coefficient and its 95% confidence interval, and the Bland-Altman plot.
- Secondary Outcome Measures
Name Time Method Radiation dose exposure for each technique 1 day Additional radiation dose exposure (CTDIvol and DLP) will be recorded and follow-up
Agreement between post-processing methods for CT through study completion (2 years) Comparison between Patlak-Ruthland method, its modified version and the area under the curve method
Intra- and inter-observer reproducibility of CT DRF measurement through study completion (2 years) Automatic post-processing for Patlak-Ruthland method through study completion (2 years)
Trial Locations
- Locations (1)
CHRU Nancy
🇫🇷Nancy, France